Fowler K - Search Results

1

LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.

Santillan C, Fowler K, Kono Y, Chernyak V. Santillan C, et al. Among authors: fowler k. Abdom Radiol (NY). 2018 Jan;43(1):75-81. doi: 10.1007/s00261-017-1291-4. Abdom Radiol (NY). 2018. PMID: 28828680 Review.

2

Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.

Fowler KJ, Sheybani A, Parker RA 3rd, Doherty S, M Brunt E, Chapman WC, Menias CO. Fowler KJ, et al. AJR Am J Roentgenol. 2013 Aug;201(2):332-9. doi: 10.2214/AJR.12.9488. AJR Am J Roentgenol. 2013. PMID: 23883213

3

Magnetic resonance imaging of iatrogeny: understanding imaging artifacts related to medical devices.

Fowler KJ, Maxwell J, Saad NE, Yano M, Raptis C, Menias C, Narra V. Fowler KJ, et al. Abdom Imaging. 2014 Apr;39(2):411-23. doi: 10.1007/s00261-013-0065-x. Abdom Imaging. 2014. PMID: 24395401 Review.

4

Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.

Shetty AS, Fowler KJ, Brunt EM, Agarwal S, Narra VR, Menias CO. Shetty AS, et al. Abdom Imaging. 2014 Apr;39(2):310-22. doi: 10.1007/s00261-013-0069-6. Abdom Imaging. 2014. PMID: 24407728

5

Hepatobiliary agents and their role in LI-RADS.

Hope TA, Fowler KJ, Sirlin CB, Costa EA, Yee J, Yeh BM, Heiken JP. Hope TA, et al. Abdom Imaging. 2015 Mar;40(3):613-25. doi: 10.1007/s00261-014-0227-5. Abdom Imaging. 2015. PMID: 25287679 Review.

6

PET/MRI for the body imager: abdominal and pelvic oncologic applications.

Fraum TJ, Fowler KJ, McConathy J, Parent EE, Dehdashti F, Grigsby PW, Siegel BA. Fraum TJ, et al. Abdom Imaging. 2015 Aug;40(6):1387-404. doi: 10.1007/s00261-015-0390-3. Abdom Imaging. 2015. PMID: 25805557 Review.

7

PET/MRI: Emerging Clinical Applications in Oncology.

Fraum TJ, Fowler KJ, McConathy J. Fraum TJ, et al. Acad Radiol. 2016 Feb;23(2):220-36. doi: 10.1016/j.acra.2015.09.008. Epub 2015 Oct 27. Acad Radiol. 2016. PMID: 26521689 Review.

8

Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma.

Zhou A, Amin M, Fowler KJ, Brunt EM, Keller J, Tan B. Zhou A, et al. J Natl Compr Canc Netw. 2015 Dec;13(12):1468-73. doi: 10.6004/jnccn.2015.0175. J Natl Compr Canc Netw. 2015. PMID: 26656516

9

Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.

Potretzke TA, Tan BR, Doyle MB, Brunt EM, Heiken JP, Fowler KJ. Potretzke TA, et al. AJR Am J Roentgenol. 2016 Jul;207(1):25-31. doi: 10.2214/AJR.15.14997. Epub 2016 Feb 11. AJR Am J Roentgenol. 2016. PMID: 26866746

10

Liver Imaging Reporting and Data System: an expert consensus statement.

Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB. Elsayes KM, et al. Among authors: fowler kj. J Hepatocell Carcinoma. 2017 Feb 17;4:29-39. doi: 10.2147/JHC.S125396. eCollection 2017. J Hepatocell Carcinoma. 2017. PMID: 28255543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,013 results

Search Page

Filters